日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trial

抗TIM-3抗体TQB2618联合penpulimab治疗既往接受过PD-1/PD-L1靶向治疗的复发或难治性经典霍奇金淋巴瘤：一项多中心、开放标签、单臂Ib期临床试验

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2026-014968
Hong, Huangming; Chen, Zegeng; Cui, Jie; Zhang, Qingyuan; Li, Ping; Tao, Rong; Huang, He; Wang, Binghua; Li, Wuping; Wu, Hui; Wei, Jin; Su, Liping; Zhang, Zhihua; Zhong, Mingxing; Wang, Huaqing; Wang, Cong; Zhou, Hui; Wang, Jishi; Dong, Min; Lin, Tongyu
PD-L1
淋巴瘤
TIM
PD-1
发表日期：2026
文献求助 收藏

Mechanisms of chemoresistance in diffuse large B‑cell lymphoma and novel therapeutic strategies (Review)

弥漫性大B细胞淋巴瘤化疗耐药机制及新型治疗策略（综述）

期刊:International Journal of Oncology
影响因子:4.9
doi:10.3892/ijo.2026.5859
Wan, Mengdi; Wang, Xi; Luo, Bin; Hong, Huangming; Zhu, Yizhun; Lin, Tongyu
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

6-month Progression-Free Survival (PFS6) as a prognostic factor in large B-cell lymphoma patients undergoing chimeric antigen receptor T-cell therapy: A real-world multicenter study

6个月无进展生存期（PFS6）作为接受嵌合抗原受体T细胞疗法的大B细胞淋巴瘤患者的预后因素：一项真实世界多中心研究

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06910-8
Wang, Zhangyan; Liu, Xiaoshi; Hong, Huangming; Lin, Tongyu
B细胞
T细胞
信号转导
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

An inflammation-integrated prognostic nomogram for advanced-stage extranodal NK/T-cell lymphoma: a multicenter retrospective study

炎症整合预后列线图在晚期结外NK/T细胞淋巴瘤中的应用：一项多中心回顾性研究

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06885-6
Xia, Yongle; Zhang, Yinjie; Li, Renqin; Zhou, Fenglan; Ye, Sheng; Zhang, Hongyu; Guo, HongQiang; Chen, Xinggui; Liang, Chaoyong; Pu, Xingxiang; Cao, Yabing; Ren, Quanguang; Li, Xiaoqian; Zhai, Linzhu; Huang, He; Huang, Zongyao; Liu, Yang; Hong, Huangming; Fang, Xiaojie
炎症
T细胞
炎症/感染
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial

莫苏妥珠单抗联合波拉妥珠单抗治疗不适合移植的难治性/复发性大B细胞淋巴瘤：III期SUNMO试验的主要结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01957
Budde, Lihua E; Zhang, Huilai; Kim, Won-Seog; Maruyama, Dai; Rego, Eduardo M; Norasetthada, Lalita; Hong, Huangming; Ozcan, Muhit; Jeon, Young-Woo; Leão Cordeiro de Farias, Danielle; Fogliatto, Laura Maria; Pavlovsky, Astrid; Goto, Hideki; Olszewski, Adam J; Shah, Nikesh; Hu, Bei; Yin, Shen; Wu, Hao; To, Iris; Ead, Wahib S; Ashby, Joan; Janousek, Martin; Pham, Song; Wang, Jue; Kwan, Antonia; Batlevi, Connie L; Wei, Michael C; Westin, Jason
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma

一项针对复发和/或难治性外周T细胞淋巴瘤患者的HH2853治疗的多中心、开放标签、单臂Ib期临床试验

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-025-01697-z
Hong, Huangming; Chen, Zegeng; Zhang, Mingzhi; Peng, Zhigang; Shen, Jianzhen; Shuang, Yuerong; Zhou, Hui; Guo, Hongqiang; Huang, He; Li, Fei; Qian, Zhengzi; Liu, Lihong; Wang, Liang; Yang, Wei; Zhang, Liling; He, Pengcheng; Qian, Shen; Li, Fugen; Li, Meng; Lin, Tongyu
T细胞
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Low prognostic nutritional index predicts poor outcome in newly diagnosed angioimmunoblastic T-cell lymphoma

低预后营养指数预示着新诊断的血管免疫母细胞性T细胞淋巴瘤预后不良。

期刊:Frontiers in Nutrition
影响因子:5.1
doi:10.3389/fnut.2025.1622691
Li, Renqin; Zhang, Wei; Yu, Le; Wu, Ping; Huang, He; Guo, Hongqiang; Lin, Tongyu; Hong, Huangming; Weng, Huawei
T细胞
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Implications of mechanosensitive ion channels in the pathogenesis of osteoarthritis: a comprehensive review

机械敏感性离子通道在骨关节炎发病机制中的作用：一项综合综述

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2025.1549812
Zhang, Yuelong; Zhuang, Huangming; Ren, Xunshan; Zhou, Panghu
关节炎
发表日期：2025
文献求助 收藏

Comprehensive analyses reveal the promising value of gasdermins as prognostic biomarkers and immunotherapeutic targets in head and neck squamous cell carcinoma

综合分析揭示了gasdermins作为头颈部鳞状细胞癌预后生物标志物和免疫治疗靶点的潜在价值

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e41213
Huang, Huageng; Ge, Jingjing; Lu, Shunzhen; Deng, Xinyi; Tian, Ying; Huang, He; Wang, Zhao; Yao, Yuyi; Hong, Huangming; Lin, Tongyu
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma

ZBED4：肝细胞癌的预后生物标志物和治疗靶点

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S546808
Ding, Jing; Zou, Xia; Huang, Xuefeng; Yu, Le; Hong, Huangming; Lin, Tongyu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏